BiOptic Inc. (TPEX:6850)
Taiwan · Delayed Price · Currency is TWD 39.45
0.00 (0.00%)
Apr 2, 2026, 1:19 PM CST
BiOptic Market Cap
BiOptic has a market cap or net worth of 1.31 billion as of April 2, 2026. Its market cap has increased by 5.07% in one year.
Market Cap
1.31B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
39.45
Market Cap Chart
Since November 10, 2021, BiOptic's market cap has increased from 1.23B to 1.31B, an increase of 5.95%. That is a compound annual growth rate of 1.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 1.31B | -0.88% |
| Dec 31, 2025 | 1.32B | 1.58% |
| Dec 31, 2024 | 1.30B | -2.59% |
| Dec 29, 2023 | 1.33B | 17.65% |
| Dec 30, 2022 | 1.13B | 7.14% |
| Dec 30, 2021 | 1.06B | -14.29% |
| Nov 10, 2021 | 1.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Advagene Biopharma | 1.60B |
| GenMont Biotech Incorporation | 1.58B |
| NeoCore Technology | 1.40B |
| Abnova (Taiwan) | 1.38B |
| Enimmune | 1.33B |
| Great Novel Therapeutics Biotech & Medicals | 1.30B |
| Meribank Biotech | 1.17B |
| GeneReach Biotechnology | 1.09B |